Shanrong Zhao and Baohong Zhang

Additional information is available at the end of the chapter

http://dx.doi.org/10.5772/61197

#### **Abstract**

[62] Yi H, Hallowell N, Griffiths S, Yeung Leung T. Motivations for undertaking DNA se‐ quencing-based non-invasive prenatal testing for fetal aneuploidy: a qualitative

study with early adopter patients in Hong Kong. PLoS One 2013 Jan;8:e81794.

2013 Nov 19; DOI: 10.1373/clinchem.2013.202663

426 Next Generation Sequencing - Advances, Applications and Challenges

Med Wkly 2013;143:w13915.

11; DOI: 10.1038/ejhg.2013.205

nat Diagn 2015 Aug 5; DOI: 10.1002/pd.4666

tudes. Public Health Genomics 2012 Jan;15:73–81.

2015 Jul 13;314:162–9.

2012;6:517–528.

[63] Bianchi DW, Wilkins-Haug L. Integration of noninvasive DNA testing for aneuploi‐ dy into prenatal care: what has happened since the rubber met the road? Clin Chem

[64] Manegold-Brauer G, Berg C, Flöck A, Rüland A, Gembruch U, Geipel A. Uptake of non-invasive prenatal testing (NIPT) and impact on invasive procedures in a tertiary referral center. Arch Gynecol Obstet 2015 Feb 26; DOI: 10.1007/s00404-015-3674-5 [65] Manegold-Brauer G, Kang Bellin A, Hahn S, De Geyter C, Buechel J, Hoesli I, et al. A new era in prenatal care: non-invasive prenatal testing (NIPT) in Switzerland. Swiss

[66] Bianchi DW, Chudova D, Sehnert AJ, Bhatt S, Murray K, Prosen TL, et al. Noninva‐ sive prenatal testing and incidental detection of occult maternal malignancies. JAMA

[67] Hahn S, Hoesli I, Lapaire O. Non-invasive prenatal diagnostics using next generation sequencing: technical, legal and social challenges. Expert Opin Med Diagn

[68] Skirton H, Goldsmith L, Jackson L, Lewis C, Chitty L. Offering prenatal diagnostic tests: European guidelines for clinical practice guidelines. Eur J Hum Genet 2013 Sep

[69] Sachs A, Blanchard L, Buchanan A, Bianchi DW. Recommended pre-test counseling points for noninvasive prenatal testing using cell-free DNA: a 2015 perspective. Pre‐

[70] Kelly SE, Farrimond HR. Non-invasive prenatal genetic testing: a study of public atti‐

[71] Warsof SL, Larion S, Abuhamad AZ. Overview of the impact of noninvasive prenatal testing on diagnostic procedures. Prenat Diagn 2015 Apr 14; DOI: 10.1002/pd.4601

RNA-seq has become increasingly popular in transcriptome profiling. One of the major challenges in RNA-seq data analysis is the accurate mapping of junction reads to their genomic origins. To detect splicing sites in short reads, many RNA-seq aligners use reference transcriptome to inform placement of junction reads. However, no systematic evaluation has been performed to assess or quantify the benefits of incorporating reference transcriptome in mapping RNA-seq reads. Meanwhile, there exist multiple human genome annotation databases, including RefGene (RefSeq Gene), Ensembl, and the UCSC annotation database. The impact of the choice of an annotation on estimating gene expression remains insufficiently investigated.

In this chapter, we systematically characterized the impact of genome annotation choice on read mapping and gene quantification by analyzing a RNA-seq dataset generated by Illumina's Human Body Map 2.0 Project. The impact of a gene model on mapping of non-junction reads is different from junction reads. We demonstrated that the choice of a gene model has a dramatic effect on both gene quantification and differential analysis. Our research will help RNA-seq data analysts to make an informed choice of gene model in practical RNA-seq data analysis.

**Keywords:** RNA-seq, gene quantification, gene model, RefSeq, UCSC, Ensembl
